德国养老院居民口服抗凝药使用模式及治疗选择预测因素
多数患者首选苯丙香豆素(58.0%),其次为利伐沙班(28.1%),NOAC使用逐年增加;既往卒中预测初始选用NOAC(aOR 1.76),肾病预测选用VKA(aOR 0.66),卒中(aOR 2.55)、出血事件和近期住院预测从VKA转换为NOAC。
要点
- 德国养老院新入院患者初始抗凝以苯丙香豆素为主(58.0%),利伐沙班次之(28.1%)。
- 既往卒中者更可能初始选用NOAC(aOR 1.76,95%CI 1.49-2.08),肾病患者更可能选用VKA(aOR 0.66,95%CI 0.59-0.75)。
- 从VKA转换为NOAC的预测因素包括卒中(aOR 2.55,95%CI 2.00-3.24)、出血事件和近期住院。
核心结论
- NOAC在德国养老院中的使用日益增加,既用于初始抗凝也用于VKA经治患者的转换。
- 从VKA转换为NOAC受疗效、安全性及减少血液监测等实用性因素影响。
研究设计与样本
- 中位年龄85岁,女性占75%,44%患有肾脏疾病。
主要发现
- 首选口服抗凝药为苯丙香豆素(58.0%),其次为利伐沙班(28.1%)。
- 研究期间NOAC使用大幅增加。
- 房颤患者中CHADS2评分≥2者接受口服抗凝药的比例从2010年的27%升至2014年的46%。
关键数值与推荐
- 初始选用NOAC而非VKA的预测因素:既往卒中(aOR 1.76;95%CI 1.49-2.08)。
- 初始选用VKA的预测因素:肾脏疾病(aOR 0.66;95%CI 0.59-0.75)及存在人工心脏瓣膜。
- 从VKA转换为NOAC的预测因素:卒中(aOR 2.55;95%CI 2.00-3.24)、出血事件和近期住院。
临床怎么用
- 在养老院老年患者中,既往卒中可能促使临床医生初始选择NOAC。
- 合并肾脏疾病或人工心脏瓣膜的患者更可能被处方VKA。
- 发生卒中、出血或近期住院的VKA治疗患者应考虑转换为NOAC。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Information on utilization of oral anticoagulants (OACs) in nursing homes is scarce. This study aimed to (i) describe OAC use in German nursing home residents, (ii) examine factors influencing whether treatment is initiated with vitamin K antagonists (VKAs) or non-VKA oral anticoagulants (NOACs) and (iii) assess which conditions predict switching to NOAC instead of continuing VKA. METHODS: Using claims data (2010-2014), we studied a cohort of new nursing home residents aged ≥65 years receiving OAC. Further, OAC use in patients with atrial fibrillation (AF) was examined over the years. RESULTS: Overall, 16 804 patients (median age: 85 years, 75% female, 44% with renal disease) were included. The majority received phenprocoumon as first OAC (58.0%), followed by rivaroxaban (28.1%). Over the study period, NOAC use increased substantially. Initiating NOAC instead of VKA was predicted by a previous stroke (adjusted odds ratio: 1.76; 95% confidence interval: 1.49-2.08). In contrast, renal disease predicted VKA initiation (0.66; 0.59-0.75) as did the presence of a prosthetic heart valve. Switching from VKA to NOAC was predicted by a stroke (2.55; 2.00-3.24), bleeding events and a recent hospitalization. During 2010-2014, the proportion of AF patients with a CHADS2 score ≥2 receiving OAC increased from 27% to 46%. CONCLUSIONS: NOACs are increasingly used in German nursing homes, both for initial anticoagulation but also in VKA pre-treated patients. Switching from VKA to NOAC was substantially influenced by aspects such as intended higher effectiveness and safety but probably also practicability due to less blood monitoring.
引用
- Jobski K, Hoffmann F, Herget-Rosenthal S, et al. Use of oral anticoagulants in German nursing home residents: drug use patterns and predictors for treatment choice. Br J Clin Pharmacol. 2018. PMID: 29148592. doi:10.1111/bcp.13474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。